Tunable Bicontinuous Macroporous Cell Culture Scaffolds via Kinetically Controlled Phase Separation
Advanced Materials · 2025
DOI: 10.1002/adma.202410452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Oksana Y Dudaryeva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, 8092, Switzerland. Hauptthemen laut MEDLINE: Tissue Scaffolds, Cell Culture Techniques. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation (SNSF) Sinergia Project, Helmut Horten Stiftung, Open ETH project SKINTEGRITY.CH.
Abstract (Originalsprache)
3D scaffolds enable biological investigations with a more natural cell conformation. However, the porosity of synthetic hydrogels is often limited to the nanometer scale, which confines the movement of 3D encapsulated cells and restricts dynamic cell processes. Precise control of hydrogel porosity across length scales remains a challenge and the development of porous materials that allow cell infiltration, spreading, and migration in a manner more similar to natural ECM environments is desirable. Here, a straightforward and reliable method is presented for generating kinetically‐controlled macroporous biomaterials using liquid–liquid phase separation between poly(ethylene glycol) (PEG) and dextran. Photopolymerization‐induced phase separation resulted in macroporous hydrogels with tunable pore size. Varying light intensity and hydrogel composition controlled polymerization kinetics, time to percolation, and complete gelation, which defined the average pore diameter (Ø = 1–200 µm) and final gel stiffness of the formed hydrogels. Critically, for biological applications, macroporous hydrogels are prepared from aqueous polymer solutions at physiological pH and temperature using visible light, allowing for direct cell encapsulation. Human dermal fibroblasts in a range of macroporous gels are encapsulated with different pore sizes. Porosity improved cell spreading with respect to bulk gels and allowed migration in the porous biomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Macromolecular Engineering Laboratory, Department of Mechanical and Process Engineering, ETH Zurich, Zurich, 8092, Switzerland.
- Department of Orthopedics, University Medical Center Utrecht, Utrecht, 3584, Netherlands.
- Laboratory for Soft Materials and Interfaces, Department of Materials, ETH Zurich, Zurich, 8093, Switzerland.
- Department of Clinical Science, Faculty of Veterinary Medicine, Utrecht University, Utrecht, 3581CT, Netherlands.
ORCID-Profile: Oksana Y Dudaryeva, Dhananjay Deshmukh, Robert W Style, Céline Labouesse, Mark W Tibbitt
Förderung
- Swiss National Science Foundation (SNSF) Sinergia Project
- Helmut Horten Stiftung
- Open ETH project SKINTEGRITY.CH
Zitieren
APA
Dudaryeva, O. Y., Cousin, L., Krajnovic, L., Gröbli, G., Sapkota, V., Ritter, L., Deshmukh, D., Cui, Y., Style, R. W., Levato, R., Labouesse, C., & Tibbitt, M. W. (2025). Tunable Bicontinuous Macroporous Cell Culture Scaffolds via Kinetically Controlled Phase Separation. Advanced Materials. https://doi.org/10.1002/adma.202410452
Vancouver
Dudaryeva OY, Cousin L, Krajnovic L, Gröbli G, Sapkota V, Ritter L, et al. Tunable Bicontinuous Macroporous Cell Culture Scaffolds via Kinetically Controlled Phase Separation. Advanced Materials. 2025. doi:10.1002/adma.202410452
BibTeX
@article{Dudaryeva2025,
author = {Dudaryeva, Oksana Y and Cousin, Lucien and Krajnovic, Leila and Gröbli, Gian and Sapkota, Virbin and Ritter, Lauritz and Deshmukh, Dhananjay and Cui, Yifan and Style, Robert W and Levato, Riccardo and Labouesse, Céline and Tibbitt, Mark W},
title = {Tunable Bicontinuous Macroporous Cell Culture Scaffolds via Kinetically Controlled Phase Separation},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202410452}
}
EUVIMED